Clinical report demonstrates local biochemical control without pelvic toxicity in recurrent prostate cancer, suggesting an effective salvage approach.
The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patients with local recurrence of hormone-resistant prostate cancer. High-dose rate brachytherapy allowed to achieve local biochemical control of prostate cancer without toxicity to pelvic organs, thus, maintaining the quality of life.
No takes yet. Share an insight, caveat, or question.
Yagudaev et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: